* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
fall in
quarterly revenue when it reports results on May 4.
* The Atlanta Georgia-based company is expected to report
a
4.2% decrease in revenue to $65.072 million from $67.93 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data. The company's guidance on April 4 2023,
for the period ended March 31, was for revenue between $63.50
million and $66.50 million.
* Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 56 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$6.5, below its last closing price of $8.25.
The company's guidance on April 4 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between 63.5 million and -5 million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.46 -0.46 -0.29 Beat 37.5
Sep. 30 2022 -0.50 -0.57 -0.50 Beat 12.3
Jun. 30 2022 -0.42 -0.47 -0.65 Missed -38.9
Mar. 31 2022 -0.52 -0.55 -0.38 Beat 31.3
Dec. -0.36 -0.42 -0.15 Beat 63.9
31 2021
Sep. 30 2021 -0.52 -0.54 -0.33 Beat 38.9
Jun. 30 2021 -0.38 -0.39 -0.39 Met -0.9
Mar. 31 2021 -0.44 -0.34 -0.34 Met -0.6
This summary was machine generated May 3 at 02:01 GMT. All
figures in US dollars unless otherwise stated